Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database
Abstract
These data raise further doubts about the clinical effectiveness of ribavirin in infants and children with risk factors for severe disease. Selection bias, with ribavirin used for sicker children, may have influenced outcome. Nevertheless the long durations of hospitalization, ICU, ventilation, and …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
Infant
Prospective Studies
newborn
regression analysis
Clinical Trial
Multicenter Study
length of stay
severity of illness index
community-acquired infections / drug therapy
hospitalization
antiviral agents / therapeutic use*
ribavirin / therapeutic use*
respiratory syncytial virus infections / drug therapy*
respiratory syncytial virus infections / mortality
respiratory syncytial viruses*
e e wang
b j law
premature
d stephens
pmid:9099772
doi:10.1542/peds.99.3.e7
bronchiolitis / drug therapy
bronchiolitis / mortality
bronchiolitis / therapy
bronchiolitis / virology*
diseases / drug therapy
respiratory syncytial virus infections / classification
Access
Citation
ID:
118477
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
118477
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet